Wanbury Under Lens for Illegal Export of Diabetes Drug

Monday, October 24, 2016

Source: The Economic Times

The Indian drug regulators, who were grappling with issues of quality, have a new beast to deal with — illegal export of drugs through repackaging by third party sources, a menace that adds to the growing number of quality issues for the drug industry. 

Mumbai-based Wanbury, one of the leading active pharmaceutical ingredients (API) manufacturers of metformin hydrochloride — a diabetic drug — was caught by the Maharashtra Food and Drug Administration for illegally export of drugs through repackaging by third party sources, a menace that adds to the growing number of quality issues for the drug industry. 

Mumbai-based Wanbury was caught by the Maharashtra Food and Drug Administration for illegally exporting this drug to Mexico, Brazil, Bangladesh and Pakistan.

View All News »